Figure 3. SE-induced hippocampal damage is attenuated by inhibition of TrkB kinase.
(A) Representative images of immunostaining of NeuN and GFAP in the hippocampal CA3b region ipsilateral to the infusion site in WT and TrkBF616A mice in respective PBS controls, SE-vehicle treated, and SE-1NMPP1 treated mice, scale bar = 50 µM. Insets: GFAP positive cells exhibited enhanced immunoreactivity and enlarged cell bodies and braches in SE-vehicle or 1NMPP1 treated WT mice and in SE-vehicle treated TrkBF616A mice, scale bar = 20 µM. (B) Number of NeuN positive cells within ipsilateral CA3b hippocampus was reduced in both WT and TrkBF616A mice undergoing SE and treated with vehicle thereafter compared to PBS controls (WT: ***p<0.001; TrkBF616A: ***p<0.001). 1NMPP1 treatment inhibited loss of NeuN positive cells in TrkBF616A mice (***p<0.001), but not in WT mice. Data are presented as mean ± SEM and analyzed using two-way ANOVA with Bonferroni post hoc tests, n=3–6.
